Melodia Therapeutics logo
Healthcare & Life Sciences

Melodia Therapeutics

Melodia Therapeutics is a Healthcare & Life Sciences startup based in Switzerland.

Active

About Melodia Therapeutics

Based in Switzerland, Melodia Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.

Melodia Therapeutics develops a next-generation DPP1 inhibitor using a selective non-covalent nitrile-based mechanism to treat severe neutrophil-driven inflammatory diseases affecting respiratory, dermatologic, and systemic disorders.

Explore Melodia Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Switzerland